DXCM - Dexcom Inc
IEX Last Trade
69.31
-0.310 -0.447%
Share volume: 4,612,819
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$69.62
-0.31
-0.45%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-27 | 2023-02-09 | 2023-04-27 | 2023-07-27 | 2023-10-26 | 2024-02-08 | 2024-04-25 | 2024-07-25 | |
| Assets | |||||||||
| Total Assets | 4.899 B | 5.392 B | 5.516 B | 6.821 B | 6.596 B | 6.265 B | 6.482 B | 6.799 B | |
| Current Assets | 3.399 B | 3.669 B | 3.767 B | 5.003 B | 4.698 B | 4.426 B | 4.621 B | 4.848 B | |
| Inventories | 311.000 M | 306.700 M | 366.000 M | 421.100 M | 498.600 M | 559.600 M | 589.100 M | 570.300 M | |
| Other Current Assets | 118.500 M | 153.700 M | 168.600 M | 175.600 M | 157.300 M | 139.500 M | 131.500 M | 140.400 M | |
| Short Term Investments | 118.500 M | 153.700 M | 168.600 M | 175.600 M | 157.300 M | 139.500 M | 131.500 M | 140.400 M | |
| Total Receivables | 597.100 M | 752.200 M | 652.500 M | 755.600 M | 788.500 M | 987.500 M | 984.800 M | 998.700 M | |
| Current Cash | 2.372 B | 2.456 B | 2.567 B | 3.636 B | 3.240 B | 2.724 B | 2.897 B | 3.121 B | |
| Total Non-current Assets | 1.501 B | 1.723 B | 1.749 B | 1.818 B | 1.898 B | 1.839 B | 1.862 B | 1.951 B | |
| Property Plant Equipment | 1.003 B | 1.056 B | 1.076 B | 1.078 B | 1.079 B | 1.113 B | 1.109 B | 1.183 B | |
| Other Assets | 33.700 M | 47.100 M | 32.000 M | 12.800 M | 22.300 M | 75.000 M | 23.500 M | 25.100 M | |
| Intangible Assets | 24.400 M | 173.300 M | 163.600 M | 154.200 M | 144.500 M | 134.500 M | 123.300 M | 114.500 M | |
| Goodwill | 24.700 M | 25.700 M | 25.700 M | 25.800 M | 25.300 M | 25.200 M | 23.200 M | 23.300 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 4.899 B | 5.392 B | 5.516 B | 6.821 B | 6.596 B | 6.265 B | 6.482 B | 6.799 B | |
| Total liabilities | 3.075 B | 3.260 B | 3.283 B | 4.720 B | 4.328 B | 4.196 B | 4.235 B | 4.365 B | |
| Total current liabilities | 900.500 M | 1.839 B | 1.865 B | 2.070 B | 1.679 B | 1.556 B | 1.594 B | 1.722 B | |
| Accounts Payable | 198.100 M | 237.900 M | 266.200 M | 269.100 M | 242.400 M | 276.400 M | 269.700 M | 307.000 M | |
| Other liabilities | 57.600 M | 63.800 M | 65.700 M | 69.800 M | 71.400 M | 67.000 M | 71.800 M | 70.000 M | |
| Current long term debt | 0.000 | 772.600 M | 773.200 M | 773.800 M | 124.200 M | 0.000 | 0.000 | 0.000 | |
| Long term debt | 2.029 B | 1.257 B | 1.258 B | 2.489 B | 2.490 B | 2.493 B | 2.494 B | 2.496 B | |
| Other liabilities | 57.600 M | 63.800 M | 65.700 M | 69.800 M | 71.400 M | 67.000 M | 71.800 M | 70.000 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.825 B | 2.132 B | 2.233 B | 2.100 B | 2.268 B | 2.069 B | 2.247 B | 2.434 B | |
| Common stock | 389.800 M | 386.500 M | 386.700 M | 386.700 M | 386.600 M | 384.000 M | 390.200 M | 399.200 M | |
| Retained earnings | 388.100 M | 479.900 M | 528.500 M | 644.400 M | 765.100 M | 1.021 B | 1.168 B | 1.311 B |